Lead sponsor

Christina Kruuse

2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

2

Trials led

0

Active

60

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2
2

Trials by status

Completed
1
Unknown
1

Trials led

EGRABIS1Ph 2Unknown30
EGRABINS1Ph 2Completed30